Three-dimensional topography of synthetic scaffolds induces elastin synthesis by human coronary artery smooth muscle cells

Tissue Engineering - Part A

Volumn 17, Issue 11-12, 2011, Pages 1561-1571

  Lin, Shigang ^a   Sandig, Martin ^b   Mequanint, Kibret ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; BIOSYNTHESIS; CELLS; GENE EXPRESSION; GLYCOPROTEINS; HISTOLOGY; MUSCLE; PROTEINS; THREE DIMENSIONAL; TOPOGRAPHY; TWO DIMENSIONAL;

3D CULTURE; 3D SCAFFOLDS; ANIMAL CELLS; DIFFERENTIATION MARKERS; ELASTOGENESIS; HUMAN CELLS; HUMAN CORONARY ARTERIES; MARKER PROTEINS; POLYURETHANE SCAFFOLDS; SMOOTH MUSCLES; SYNTHETIC SCAFFOLDS; THREE-DIMENSIONAL TOPOGRAPHY; TRANSFORMING GROWTH FACTORS; VASCULAR SMOOTH MUSCLE CELLS; VASCULAR TISSUE; WESTERN BLOTS;

SCAFFOLDS (BIOLOGY);

ANIMALIA;

CONTRACTILE PROTEIN; ELASTIN; FIBRONECTIN; POLYURETHAN; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BIOSYNTHESIS; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHENOTYPE; SMOOTH MUSCLE FIBER;

ADULT; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CONTRACTILE PROTEINS; CORONARY VESSELS; ELASTIN; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; POLYURETHANES; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79957613235     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0593     Document Type: Article

References (48)

1. Li, S., Lao, J., Chen, B.P., Li, Y.S., Zhao, Y., Chu, J., Chen, K.D., Tsou, T.C., Peck, K., and Chien, S. Genomic analysis of smooth muscle cells in 3-dimensional collagen matrix. FASEB J 17, 97, 2003.
2. Elliott, N.T., and Yuan, F. A review of three-dimensional in vitro tissue models for drug discovery and transport studies. J Pharm Sci 100, 59, 2011.
3. L'Heureux, N., Dusserre, N., Marini, A., Garrido, S., de la Fuente, L., and McAllister, T. Technology insight: the evolution of tissue-engineered vascular grafts-from research to clinical practice. Nat Clin Pract Cardiovasc Med 4, 389, 2007.
4. Mithieux, S.M., and Weiss, A.S. Elastin. Adv Protein Chem 70, 437, 2005.
5. Patel, A., Fine, B., Sandig, M., and Mequanint, K. Elastin biosynthesis: the missing link in tissue-engineered blood vessels. Cardiovasc Res 71, 40, 2006.
6. Karnik, S.K., Brooke, B.S., Bayes-Genis, A., Sorensen, L., Wythe, J.D., Schwartz, R.S., Keating, M.T., and Li, D.Y. A critical role for elastin signaling in vascular morphogenesis and disease. Development 130, 411, 2003.
7. Li, D.Y., Brooke, B., Davis, E.C., Mecham, R.P., Sorensen, L.K., Boak, B.B., Eichwald, E., and Keating, M.T. Elastin is an essential determinant of arterial morphogenesis. Nature 393, 276, 1998.
8. Crapo, P.M., and Wang, Y. Physiologic compliance in engineered small-diameter arterial constructs based on an elastomeric substrate. Biomaterials 31, 1626, 2010.
9. Dahl, S.L., Rhim, C., Song, Y.C., and Niklason, L.E. Mechanical properties and compositions of tissue engineered and native arteries. Ann Biomed Eng 35, 348, 2007.
10. Iwasaki, K., Kojima, K., Kodama, S., Paz, A.C., Chambers, M., Umezu, M., and Vacanti, C.A. Bioengineered three-layered robust and elastic artery using hemodynamicallyequivalent pulsatile bioreactor. Circulation 118, S52, 2008.
11. Kim, B.S., and Mooney, D.J. Engineering smooth muscle tissue with a predefined structure. J Biomed Mater Res 41, 322, 1998.
12. Long, J.L., and Tranquillo, R.T. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol 22, 339, 2003.
13. Keire, P.A., L'Heureux, N., Vernon, R.B., Merrilees, M.J., Starcher, B., Okon, E., Dusserre, N., McAllister, T.N., and Wight, T.N. Expression of versican isoform V3 in the absence of ascorbate improves elastogenesis in engineered vascular constructs. Tissue Eng Part A 16, 501, 2010.
14. McKee, J.A., Banik, S.S., Boyer, M.J., Hamad, N.M., Lawson, J.H., Niklason, L.E., and Counter, C.M. Human arteries engineered in vitro. EMBO Rep 4, 633, 2003.
15. Nelson, G.N., Mirensky, T., Brennan, M.P., Roh, J.D., Yi, T., Wang, Y., and Breuer, C.K. Functional small-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model: preliminary findings. Arch Surg 143, 488, 2008.
16. Gong, Z., and Niklason, L.E. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 22, 1635, 2008.
17. Hibino, N., Shin'oka, T., Matsumura, G., Ikada, Y., and Kurosawa, H. The tissue-engineered vascular graft using bone marrow without culture. J Thorac Cardiovasc Surg 129, 1064, 2005.
18. Stitzel, J., Liu, J., Lee, S.J., Komura, M., Berry, J., Soker, S., Lim, G., Van Dyke, M., Czerw, R., Yoo, J.J., and Atala, A. Controlled fabrication of a biological vascular substitute. Biomaterials 27, 1088, 2006.
19. Heydarkhan-Hagvall, S., Schenke-Layland, K., Dhanasopon, A.P., Rofail, F., Smith, H., Wu, B.M., Shemin, R., Beygui, R.E., and MacLellan, W.R. Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineering. Biomaterials 29, 2907, 2008.
20. Buttafoco, L., Kolkman, N.G., Engbers-Buijtenhuijs, P., Poot, A.A., Dijkstra, P.J., Vermes, I., and Feijen, J. Electrospinning of collagen and elastin for tissue engineering applications. Biomaterials 27, 724, 2006.
21. Almine, J.F., Bax, D.V., Mithieux, S.M., Nivison-Smith, L., Rnjak, J., Waterhouse, A., Wise, S.G., and Weiss, A.S. Elastin-based materials. Chem Soc Rev 39, 3371, 2010.
22. Brooke, B.S., Bayes-Genis, A., and Li, D.Y. New insights into elastin and vascular disease. Trends Cardiovasc Med 13, 176, 2003.
23. Wamhoff, B.R., Bowles, D.K., and Owens, G.K. Excitationtranscription coupling in arterial smooth muscle. Circ Res 98, 868, 2006.
24. Owens, G.K., Kumar, M.S., and Wamhoff, B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84, 767, 2004.
25. Ueki, N., Sobue, K., Kanda, K., Hada, T., and Higashino, K. Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci USA 84, 9049, 1987.
26. Yoshida, T., and Owens, G.K. Molecular determinants of vascular smooth muscle cell diversity. Circ Res 96, 280, 2005.
27. Stegemann, J.P., Hong, H., and Nerem, R.M. Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J Appl Physiol 98, 2321, 2005.
28. Grenier, S., Sandig, M., and Mequanint, K. Smooth muscle alpha-actin and calponin expression and extracellular matrix production of human coronary artery smooth muscle cells in 3D scaffolds. Tissue Eng Part A 15, 3001, 2009.
29. Grenier, S., Sandig, M., and Mequanint, K. Polyurethane biomaterials for fabricating 3D porous scaffolds and supporting vascular cells. J Biomed Mater Res A 82, 802, 2007.
30. Lincoln, T.M., Wu, X., Sellak, H., Dey, N., and Choi, C.S. Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase. Front Biosci 11, 356, 2006.
31. Hong, H., McCullough, C.M., and Stegemann, J.P. The role of ERK signaling in protein hydrogel remodeling by vascular smooth muscle cells. Biomaterials 28, 3824, 2007.
32. Hamamura, K., Jiang, C., and Yokota, H. ECM-dependent mRNA expression profiles and phosphorylation patterns of p130Cas, FAK, ERK and p38 MAPK of osteoblast-like cells. Cell Biol Int 34, 1005, 2010.
33. Cukierman, E., Pankov, R., Stevens, D.R., and Yamada, K.M. Taking cell-matrix adhesions to the third dimension. Science 294, 1708, 2001.
34. Poh, M., Boyer, M., Solan, A., Dahl, S.L., Pedrotty, D., Banik, S.S., McKee, J.A., Klinger, R.Y., Counter, C.M., and Niklason, L.E. Blood vessels engineered from human cells. Lancet 365, 2122, 2005.
35. Deng, D.X., Spin, J.M., Tsalenko, A., Vailaya, A., Ben-Dor, A., Yakhini, Z., Tsao, P., Bruhn, L., and Quertermous, T. Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli. Arterioscler Thromb Vasc Biol 26, 1058, 2006.
36. L'Heureux, N., Stoclet, J.C., Auger, F.A., Lagaud, G.J., Germain, L., and Andriantsitohaina, R. A human tissueengineered vascular media: a new model for pharmacological studies of contractile responses. FASEB J 15, 515, 2001.
37. Gong, Z., and Niklason, L.E. Blood vessels engineered from human cells. Trends Cardiovasc Med 16, 153, 2006.
38. Grainger, D.J. TGF-beta and atherosclerosis in man. Cardiovasc Res 74, 213, 2007.
39. Kucich, U., Rosenbloom, J.C., Abrams, W.R., and Rosenbloom, J. Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38. Am J Respir Cell Mol Biol 26, 183, 2002.
40. Kahari, V.M., Olsen, D.R., Rhudy, R.W., Carrillo, P., Chen, Y.Q., and Uitto, J. Transforming growth factor-beta up-regulates elastin gene expression in human skin fibroblasts. Evidence for post-transcriptional modulation. Lab Invest 66, 580, 1992.
41. Kucich, U., Rosenbloom, J.C., Abrams, W.R., Bashir, M.M., and Rosenbloom, J. Stabilization of elastin mRNA by TGFbeta: initial characterization of signaling pathway. Am J Respir Cell Mol Biol 17, 10, 1997.
42. Johnson, D.J., Robson, P., Hew, Y., and Keeley, F.W. Decreased elastin synthesis in normal development and in long-term aortic organ and cell cultures is related to rapid and selective destabilization of mRNA for elastin. Circ Res 77, 1107, 1995.
43. Parks, W.C. Posttranscriptional regulation of lung elastin production. Am J Respir Cell Mol Biol 17, 1, 1997.
44. Kothapalli, C.R., Taylor, P.M., Smolenski, R.T., Yacoub, M.H., and Ramamurthi, A. Transforming growth factor beta 1 and hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells. Tissue Eng Part A 15, 501, 2009.
45. Kothapalli, C.R., and Ramamurthi, A. Biomimetic regeneration of elastin matrices using hyaluronan and copper ion cues. Tissue Eng Part A 15, 103, 2009.
46. Joddar, B., and Ramamurthi, A. Elastogenic effects of exogenous hyaluronan oligosaccharides on vascular smooth muscle cells. Biomaterials 27, 5698, 2006.
47. Joddar, B., and Ramamurthi, A. Fragment size-and dosespecific effects of hyaluronan on matrix synthesis by vascular smooth muscle cells. Biomaterials 27, 2994, 2006.
48. Hautmann, M.B., Madsen, C.S., and Owens, G.K. A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem 272, 10948, 1997.